{"disease":{"id":"adenocarcinoma-of-the-esophagogastric-junction","name":"adenocarcinoma of the esophagogastric junction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05419349","title":"Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database","phase":"","overall_status":"COMPLETED","enrollment_count":1819,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT05872685","title":"Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":314,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT07095699","title":"Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":314,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06347757","title":"A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Northern Jiangsu People's Hospital","has_results":false},{"nct_id":"NCT03647540","title":"The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric Junction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":164,"lead_sponsor_name":"Dong Yang","has_results":false},{"nct_id":"NCT05729646","title":"Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT02287129","title":"Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT06681298","title":"A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"xiaohua li","has_results":false},{"nct_id":"NCT05970627","title":"Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT05715931","title":"Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Yu jiren","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}